APA (7th ed.) Citation

P, D. B., V, L., P, R., O, B., F, C., N, P., . . . R, G. (2018). Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy. Arthritis research & therapy, 20(1), 223. https://doi.org/10.1186/s13075-018-1719-4

Chicago Style (17th ed.) Citation

P, Di Benedetto, et al. "Blocking CD248 Molecules in Perivascular Stromal Cells of Patients with Systemic Sclerosis Strongly Inhibits Their Differentiation Toward Myofibroblasts and Proliferation: A New Potential Target for Antifibrotic Therapy." Arthritis Research & Therapy 20, no. 1 (2018): 223. https://doi.org/10.1186/s13075-018-1719-4.

MLA (9th ed.) Citation

P, Di Benedetto, et al. "Blocking CD248 Molecules in Perivascular Stromal Cells of Patients with Systemic Sclerosis Strongly Inhibits Their Differentiation Toward Myofibroblasts and Proliferation: A New Potential Target for Antifibrotic Therapy." Arthritis Research & Therapy, vol. 20, no. 1, 2018, p. 223, https://doi.org/10.1186/s13075-018-1719-4.